BIONET Corp. (TPEX:1784)
99.10
+0.80 (0.81%)
At close: Dec 5, 2025
BIONET Revenue
BIONET had revenue of 297.95M TWD in the quarter ending September 30, 2025, a decrease of -1.96%. This brings the company's revenue in the last twelve months to 1.22B, up 3.76% year-over-year. In the year 2024, BIONET had annual revenue of 1.22B with 8.40% growth.
Revenue (ttm)
1.22B
Revenue Growth
+3.76%
P/S Ratio
4.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22B | 94.73M | 8.40% |
| Dec 31, 2023 | 1.13B | 146.93M | 14.99% |
| Dec 31, 2022 | 980.38M | 58.96M | 6.40% |
| Dec 31, 2021 | 921.42M | 114.85M | 14.24% |
| Dec 31, 2020 | 806.58M | 31.02M | 4.00% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 34.99M |
| PharmaEssentia | 13.82B |
| Heron Neutron Medical | 5.53M |
| Lotus Pharmaceutical | 18.66B |
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Oneness Biotech | 117.33M |
| Lumosa Therapeutics | 42.59M |
| Center Laboratories | 1.57B |